Expression of Epidermal Growth Factor Receptor-Related Family Products in Gestational Trophoblastic Diseases and Normal Placenta and Its Relationship with Development of Postmolar Tumor
- 1 June 2000
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 77 (3) , 389-393
- https://doi.org/10.1006/gyno.2000.5777
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2Human Pathology, 1998
- Relative expression of epidermal growth factor receptor in placental cytotrophoblasts and choriocarcinoma cell linesPlacenta, 1997
- Chorionic TumorsNew England Journal of Medicine, 1996
- Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta.Endocrinology, 1995
- Transcriptional and posttranscriptional mechanisms in epidermal growth factor regulation of human chorionic gonadotropin (hCG) subunits and hCG receptor gene expression in human choriocarcinoma cells.Endocrinology, 1994
- Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblastsCancer, 1993
- Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R.Journal of Histochemistry & Cytochemistry, 1993
- The type 1 (EGFR-related) family of growth factor receptors and their ligandsProgress in Growth Factor Research, 1992
- Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.Proceedings of the National Academy of Sciences, 1989
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984